首页> 外文期刊>Open Heart >The OxVALVE population cohort study (OxVALVE-PCS)—population screening for undiagnosed valvular heart disease in the elderly: study design and objectives
【24h】

The OxVALVE population cohort study (OxVALVE-PCS)—population screening for undiagnosed valvular heart disease in the elderly: study design and objectives

机译:OxVALVE人群队列研究(OxVALVE-PCS)-筛查老年人未确诊的心脏瓣膜病的人群:研究设计和目标

获取原文
       

摘要

Introduction Valvular heart disease (VHD) is an increasingly important cardiac condition, driven by an ageing population and lack of progress in the development of medical therapies. There is a dearth of accurate information to guide decision-makers in the development of strategies to combat VHD, and no population-based study has been performed specifically to investigate its contemporary epidemiology. This document describes the design and methodology of the OxVALVE population cohort study (OxVALVE-PCS), which was conceived to address this need. Methods and analysis Participants aged 65?years and older attending a participating general practice in Oxfordshire, UK, are invited to attend a screening examination. Exclusion criteria include previously diagnosed VHD, inability to provide consent, terminal illness or excessive frailty. Demographics, a focused cardiovascular history and vital signs are recorded at the initial screening examination, accompanied by an echocardiogram. Any finding of significant VHD triggers a separate, more formal echocardiographic assessment (including acquisition of a three-dimensional dataset) and collection of blood samples for future genetic and biomarker analysis. Participants provide consent for longitudinal follow-up and enrolment in future cohort substudies. We also assess the acceptability of community-based echocardiographic examination and compare self-assessed quality of life between those with and without VHD. Conclusions OxVALVE-PCS will provide contemporary epidemiological data concerning the community prevalence of undiagnosed VHD, facilitate accurate deployment of scarce resources to meet the anticipated increase in demand for VHD-associated healthcare and create a series of subcohorts with carefully defined genotypes and echocardiographic phenotypes for long overdue clinical studies. Ethics and dissemination This study was approved by the local research ethics committee (Southampton, UK; REC Ref: 09/H0502/58). Results Results will be submitted for publication in peer-reviewed scientific journals.
机译:简介瓣膜性心脏病(VHD)是一种日益重要的心脏病,其原因是人口老龄化和药物治疗的发展缺乏进展。目前尚缺乏准确的信息来指导决策者制定对抗VHD的策略,并且还没有专门针对其现代流行病学进行基于人群的研究。本文描述了旨在解决这一需求的OxVALVE人群队列研究(OxVALVE-PCS)的设计和方法。方法与分析65岁及以上的参与者参加了在英国牛津郡参加的普通实践,被邀请参加筛查。排除标准包括先前诊断的VHD,无法提供同意,绝症或过度虚弱。初始筛查时会记录人口统计学,有重点的心血管病史和生命体征,并伴有超声心动图。任何重大VHD的发现都会触发单独的,更正式的超声心动图评估(包括获取三维数据集)并采集血液样本以用于将来的遗传和生物标记分析。参加者同意进行纵向随访并参加将来的队列研究。我们还评估了基于社区的超声心动图检查的可接受性,并比较了有和没有VHD者的自我评估生活质量。结论OxVALVE-PCS将提供有关未确诊的VHD社区患病率的当代流行病学数据,促进准确部署稀缺资源,以满足对VHD相关医疗保健需求的预期增长,并创建一系列具有明确定义的基因型和超声心动图表型的亚人群临床研究逾期。伦理与传播这项研究得到了当地研究伦理委员会(英国南安普敦; REC参考:09 / H0502 / 58)的批准。结果结果将提交在同行评审的科学期刊上发表。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号